Steven Cohen Bicycle Therapeutics PLC Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 899,799 shares of BCYC stock, worth $13.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

899,799

Previous 58,500 1438.12%

Holding current value

$13.1 Million

Previous $1.18 Million 1623.56%

% of portfolio

0.06%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.58 - $27.24 $16.5 Million - $22.9 Million	841,299 Added 1438.12%	899,799 $20.4 Million
Q2 2024 Aug 14, 2024	SELL	$20.02 - $24.69 $5.69 Million - $7.01 Million	-284,094 Reduced 82.92%	58,500 $1.18 Million
Q1 2024 May 15, 2024	BUY	$16.75 - $26.1 $1.95 Million - $3.05 Million	116,699 Added 51.66%	342,594 $8.53 Million
Q4 2023 Feb 14, 2024	SELL	$13.29 - $22.2 $14.3 Million - $23.8 Million	-1,073,605 Reduced 82.62%	225,895 $4.08 Million
Q3 2023 Nov 14, 2023	BUY	$19.9 - $26.25 $16.3 Million - $21.6 Million	821,500 Added 171.86%	1,299,500 $26.1 Million
Q2 2023 Aug 14, 2023	SELL	$18.95 - $28.67 $6.15 Million - $9.3 Million	-324,400 Reduced 40.43%	478,000 $12.2 Million
Q1 2023 May 15, 2023	SELL	$20.02 - $31.37 $4.12 Million - $6.45 Million	-205,578 Reduced 20.4%	802,400 $17.1 Million
Q4 2022 Feb 14, 2023	SELL	$20.37 - $32.9 $5.04 Million - $8.14 Million	-247,440 Reduced 19.71%	1,007,978 $29.8 Million
Q3 2022 Nov 14, 2022	SELL	$17.49 - $28.44 $3.32 Million - $5.39 Million	-189,582 Reduced 13.12%	1,255,418 $29.2 Million
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $2.26 Million - $8.21 Million	-174,802 Reduced 10.79%	1,445,000 $24.2 Million
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $1.88 Million - $2.8 Million	46,979 Added 2.99%	1,619,802 $71.1 Million
Q4 2021 Feb 14, 2022	SELL	$41.7 - $61.14 $1.76 Million - $2.58 Million	-42,269 Reduced 2.62%	1,572,823 $95.7 Million
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $5.33 Million - $8.44 Million	-190,843 Reduced 10.57%	1,615,092 $67.2 Million
Q2 2021 Aug 16, 2021	BUY	$27.0 - $32.28 $6.17 Million - $7.37 Million	228,442 Added 14.48%	1,805,935 $54.8 Million
Q1 2021 May 17, 2021	BUY	$19.12 - $30.25 $2.68 Million - $4.23 Million	139,917 Added 9.73%	1,577,493 $47.1 Million
Q4 2020 Feb 16, 2021	BUY	$17.95 - $21.36 $1.34 Million - $1.59 Million	74,425 Added 5.46%	1,437,576 $25.8 Million
Q3 2020 Nov 16, 2020	BUY	$15.3 - $20.8 $14.7 Million - $20 Million	962,652 Added 240.36%	1,363,151 $26 Million
Q1 2020 May 15, 2020	BUY	$9.82 - $18.0 $176,760 - $324,000	18,000 Added 4.71%	400,499 $5.47 Million
Q4 2019 Feb 14, 2020	BUY	$7.68 - $11.08 $2.94 Million - $4.24 Million	382,499 New	382,499 $3.61 Million

Others Institutions Holding BCYC

# of Institutions

111

Shares Held

40.8M

Call Options Held

39.6K

Put Options Held

24.6K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $431M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account